Cargando…
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020
BACKGROUND: The majority of current pharmacological treatments for Parkinson’s disease (PD) were approved for clinical use in the second half of the last century and they only provide symptomatic relief. Derivatives of these therapies continue to be explored in clinical trials, together with potenti...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458531/ https://www.ncbi.nlm.nih.gov/pubmed/32741777 http://dx.doi.org/10.3233/JPD-202128 |